AstraZeneca PLC (AZN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
Year-to-Date Core EPS Growth (2024): 11% increase. Emerging Markets Growth (Year-to-Date 2024): 30% increase outside of China. Oncology Total Revenue (First Nine Months 2024): $16 billion, 22% growth. BioPharmaceuticals Total Revenue (First Nine Months 2024): $15.9 billion, 20% growth. Rare Disease Revenue (First Nine Months 2024): $6.4 billion, 14% growth. Net Cash Inflow from Operating Activities (First Nine Months 2024): Improved by $989 million. CapEx (Year-to-Date 2024): $1.2 billion. Net Debt Increase (First Nine Months 2024): $3.8 billion. Net Debt to EBITDA Ratio: 1.8 times. Full Year Guidance Upgrade (2024): Total revenue and core EPS expected to grow by high 10s percentage. Warning! GuruFocus has detected 5 Warning Sign with AZN. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript AstraZeneca PLC ( NASDAQ:AZN ) reported a 21% increase in total revenue for Q3, driven by
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Pillar Biosciences to Present Impactful Research Data at 2024 Association for Molecular Pathology (AMP) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Silence Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]Yahoo! Finance
- Lost Money on AstraZeneca PLC (AZN)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire
- Is AstraZeneca a Buy as It Eyes the Weight Loss Market? [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy [CNBC]CNBC
AZN
Sec Filings
- 11/13/24 - Form 6-K
- 11/12/24 - Form 6-K
- 11/12/24 - Form 6-K
- AZN's page on the SEC website